• Register
  • Login

Iranian Journal of Child Neurology

  • Home
  • About
    • About the Journal
    • Indexing & Abstracting
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Current
  • Archives
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 5 No. 3 (2011): Iranian Journal of Child Neurology;Summer 2011
  4. Research Article

Vol. 5 No. 3 (2011)

July 2011

Risk Factors for the Development of Critical Illness Polyneuropathy and Myopathy in a Pediatric Intensive Care Unit

  • Nemat Bilan
  • Mir Reza Gaemi
  • Shadi Shiva

Iranian Journal of Child Neurology, Vol. 5 No. 3 (2011), 1 July 2011 , Page 23-28
https://doi.org/10.22037/ijcn.v5i3.2403 Published: 2011-07-01

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract


Objective

Critical illness polyneuropathy and myopathy (CIPNM) is a major complication of severe critical illness. Previous studies have suggested that many risk factors such as sepsis, multiorgan failure, and neuromuscular blocking agents play a role in CIPNM pathogenesis. The aim of this study was to evaluate possible risk factors in the development of CIPNM in a pediatric intensive care unit (PICU). 

Materials & Methods


In this observational study, we recruited 57 patients admitted in the PICU of the Tabriz Pediatric Hospital. CIPNM was diagnosed in 13 (22.8%) patients on the basis of the clinical and electrodiagnostic findings. Different variables such as age, sex, the pediatric risk of mortality (PRISM) score, duration of mechanical ventilation and PICU stay, accompanying pathologic conditions, medications, and in-hospital outcome were compared between the CIPNM and non-CIPNM groups.

Results


Compared to the non-CIPNM patients, the CIPNM patients showed significantly more frequent sepsis (6.8% vs. 38.5%, odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.7-43.1) and multiorgan dysfunction (43.2% vs. 76.9%, OR = 4.4, 95% CI = 1.1-18.2). Midazolam was administered more frequently in the non-CIPNM group than in the CIPNM group (88.6% vs. 53.8%, OR =0.2, 95% CI = 0.0-0.6). There was no significant difference between the 2 groups withrespect to parameters such as age, sex, PRISM score, duration of mechanical ventilation and PICU stay, other accompanying pathologic conditions, and other medications. The mortality rate was 4.5% in the non-CIPNM group and 15.4% in the CIPNM group.In the multivariable analysis, sepsis and midazolam administration were the only significant contributors to the development of CIPNM.

Conclusion


Sepsis is an independent risk factor for the development of CIPNM. However, midazolam administration seems to be an independent protective factor against CIPNM.
Keywords: Critical illness polyneuropathy and Myopathy; pediatric intensive care unit; risk factors    

  • PDF

How to Cite

Bilan, N., Gaemi, M. R., & Shiva, S. (2011). Risk Factors for the Development of Critical Illness Polyneuropathy and Myopathy in a Pediatric Intensive Care Unit. Iranian Journal of Child Neurology, 5(3), 23–28. https://doi.org/10.22037/ijcn.v5i3.2403
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 429 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus